Dr. Vaduganathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Brigham and Women's Hospital
75 Francis St.
Boston, MA 02115
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2015 - 2019- Massachusetts General HospitalFellowship, Cardiovascular Disease, 2016 - 2017
- Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2015
- Northwestern University The Feinberg School of MedicineClass of 2012
Certifications & Licensure
- MA State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Integrating Ketone Bodies in Multi-Marker Risk Prediction of Incident Heart Failure in the Multi-Ethnic Study of Atherosclerosis (MESA).Parag Anilkumar Chevli, Senthil Selvaraj, Byron C Jaeger, Aziz Hammoud, Margery A Connelly
European Journal of Preventive Cardiology. 2025-03-21 - Vericiguat Adherence for Heart Failure With Reduced Ejection Fraction in Routine Clinical Care in the U.S.Naira Ikram, Ankeet Bhatt, Muthiah Vaduganathan, Rishi J Desai
JACC. Heart Failure. 2025-03-10 - Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model: A Secondary Analysis of FINEARTS-HF.Kirsty McDowell, Kieran F Docherty, Ross T Campbell, Alasdair D Henderson, Pardeep S Jhund
JAMA Cardiology. 2025-03-05
Journal Articles
- Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical PracticeMuthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
- Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular DiseaseMichael C Honigberg, Darren K Mcguire, Muthiah Vaduganathan, JAMA Cardiology
- Emerging Trends in Financing of Adult Heart Transplantation in the United StatesMuthiah Vaduganathan, Josef Stehlik, Mandeep R Mehra, JACC: Cardiovascular Imaging
- Join now to see all
Authored Content
- Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular DiseaseJune 2020
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19April 2020
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19April 2020
- Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients with Type 2 DiabetesMarch 2018
- Oral Anticoagulation in Patients with Liver DiseaseMarch 2018
- Join now to see all
Press Mentions
- JACC - Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: LookAHEAD Cardiac Biomarker Ancillary StudyNovember 20th, 2024
- LookAHEAD Cardiac Biomarker Ancillary Study | JACC | AHA 2024November 16th, 2024
- Part Two: Time to Significant Benefit of Finerenone in Patients with Heart Failure | JACC | HFSA 2024October 4th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
